Atlas Trials

Phase II Randomized Study Evaluating the Efficacy of Panitumumab (VEctibix ) and Trifluridine-Tipiracil (LOnsurf) in Pretreated RAS Wild Type Metastatic Colorectal Cancer Patients: the VELO Trial

Clinical trial NCT05468892 · COMPLETED

Trial details

NCT number
NCT05468892
Sponsor
University of Campania Luigi Vanvitelli
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colon Cancer
Start date
2019-10-29
Primary completion
2022-05-31
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.